Knowledge (XXG)

Dithranol

Source 📝

685:
result from both an inhibition of DNA synthesis as well as from its strong reducing properties. Anthralin’s effectiveness as an anti-psoriatic agent has also been in part attributed to its abilities to induce lipid peroxidation and reduce levels of endothelial adhesion molecules which are markedly elevated in psoriatic patients. Unlike retinoids and PUVA, anthralin does not inhibit liver microsomal enzyme activity; consequently, the likelihood of adverse drug interactions is greatly reduced when other agents are administered concomitantly with anthralin.
448: 425: 40: 49: 661:
local burning sensation and irritation; this may be minimised by careful attention to the details of treatment and only gradually stepping up through the strengths of dithranol formulations. The surrounding skin can be protected using soft white paraffin and the treated area is covered with tube gauze.
684:
Anthralin is a synthetic compound whose precise mechanism of anti-psoriatic action is not yet fully understood. However, numerous studies have demonstrated anti-proliferative and anti-inflammatory effects of anthralin on psoriatic and normal skin. The anti-proliferative effects of anthralin appear to
660:
It temporarily stains the skin a yellowy-brown to purple if not washed off after a period of time (45-60 minutes). It permanently stains clothing fabrics, shower curtains, and other materials such as ceramic sinks the same yellow-brown to purple in color depending on the concentration. It may cause a
688:
More dithranol penetrates into impaired skin in 30 minutes than into intact skin during about 16 hours. For this reason weaker 0.1-0.5% preparations are applied over night, but stronger 1-2% products are applied for between 30 minutes and one hour depending upon the formulation.
625:. It is available as creams, ointment or pastes in 0.1 to 2% strengths (Drithocreme, Dithrocream, Zithranol-RR, Micanol, Psorlin, Dritho-Scalp, Anthraforte, Anthranol and Anthrascalp). The terms dithranol and anthralin are sometimes used synonymously. 1043: 117: 677:. This impedes DNA replication and so slows the excessive cell division that occurs in psoriatic plaques. In addition Dithranol may act by reducing the elevated levels of 1036: 61: 535: 644:, but is without the potential for rebound reaction on withdrawal. It cannot be used on the face or genitalia. There is some tentative evidence that 1029: 781: 893: 987: 594: 555: 242: 147: 678: 511: 774: 324: 1225: 1004: 404: 1106: 602: 1220: 1205: 992: 767: 673:
where it interferes with the supply of energy to the cell, probably by the oxidation of dithranol releasing
105: 443: 191: 1230: 1086: 606: 393: 1215: 1091: 1052: 211: 1176: 420: 259: 750: 1055: 162: 79: 1136: 1131: 1166: 729: 373: 1210: 719: 460: 173: 333: 649: 313: 268: 201: 181: 447: 424: 998: 638: 1199: 790: 522: 436: 888: 877: 794: 674: 670: 563:
InChI=1S/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6,15-16H,7H2
130: 125: 39: 1021: 48: 759: 293: 1161: 1156: 941: 936: 861: 964: 909: 903: 898: 856: 830: 618: 614: 487: 304: 1146: 1126: 969: 946: 883: 724: 707: 645: 634: 622: 224: 71: 65: 733: 31: 1184: 1151: 1121: 1101: 1081: 1076: 956: 848: 820: 610: 17: 1116: 1111: 1071: 1063: 641: 279: 384: 353: 1141: 510: 501: 364: 344: 156: 1025: 763: 712:
The Journal of Investigative Dermatology. Symposium Proceedings
816: 409: 90: 580: 633:
Dithranol has a slower onset of action in controlling
1175: 1062: 955: 929: 922: 870: 847: 829: 809: 802: 521: 499: 486: 459: 454: 435: 403: 383: 363: 343: 323: 303: 278: 258: 233: 223: 210: 200: 190: 180: 172: 146: 141: 116: 104: 78: 60: 55: 292: 267: 1037: 775: 8: 30: 1044: 1030: 1022: 926: 806: 782: 768: 760: 446: 423: 312: 723: 332: 250:1,8-dihydroxy-9,10-dihydroanthracen-9-one 72:Micromedex Detailed Consumer Information 698: 637:, typically several weeks, compared to 560: 540: 419: 247: 708:"Current treatment of alopecia areata" 437: 29: 392: 372: 206:absorbed and oxidised within the skin 70: 7: 129: 621:applied to the skin of people with 352: 283: 25: 1107:Diazepam binding inhibitor (DBI) 471: 47: 38: 568:Key:NUZWLKWWNNJHPT-UHFFFAOYSA-N 477: 465: 1: 186:0%, trace amounts metabolites 543:O=C2c1c(O)cccc1Cc3c2c(O)ccc3 706:Shapiro J (December 2013). 681:that occurs in psoriasis. 617:derivative, and is used in 1247: 894:Calcipotriol/betamethasone 751:British National Formulary 455:Chemical and physical data 982: 669:Dithranol accumulates in 576: 551: 531: 527:178 °C (352 °F) 238: 46: 37: 791:Drugs used for psoriasis 725:10.1038/jidsymp.2013.14 1097:Dithranol (anthralin) 1092:Deuterated etifoxine 1053:Translocator protein 648:might be useful for 34: 1226:3-Hydroxypropenals 1087:DBI 17-50 fragment 1009:Never to phase III 163:Pharmacy medicines 1193: 1192: 1019: 1018: 978: 977: 918: 917: 588: 587: 512:Interactive image 405:CompTox Dashboard 160: 94: 27:Chemical compound 16:(Redirected from 1238: 1221:Aromatic ketones 1046: 1039: 1032: 1023: 927: 807: 784: 777: 770: 761: 738: 737: 727: 703: 584: 583: 514: 494: 479: 473: 467: 450: 439: 428: 427: 413: 411: 396: 376: 356: 336: 316: 296: 286: 285: 271: 215: 158: 155: 133: 92: 89: 74: 51: 42: 35: 33: 21: 1246: 1245: 1241: 1240: 1239: 1237: 1236: 1235: 1196: 1195: 1194: 1189: 1171: 1058: 1050: 1020: 1015: 1014: 999:Clinical trials 974: 951: 914: 866: 843: 825: 798: 788: 747: 745:Further reading 742: 741: 705: 704: 700: 695: 667: 658: 650:alopecia areata 631: 579: 577: 572: 569: 564: 559: 558: 547: 544: 539: 538: 517: 492: 482: 476: 470: 431: 407: 399: 379: 359: 339: 319: 299: 282: 274: 254: 251: 246: 245: 213: 192:Protein binding 182:Bioavailability 174:Pharmacokinetic 168: 137: 107: 100: 81: 28: 23: 22: 15: 12: 11: 5: 1244: 1242: 1234: 1233: 1228: 1223: 1218: 1213: 1208: 1206:Antipsoriatics 1198: 1197: 1191: 1190: 1188: 1187: 1181: 1179: 1173: 1172: 1170: 1169: 1164: 1159: 1154: 1149: 1144: 1139: 1134: 1129: 1124: 1119: 1114: 1109: 1104: 1099: 1094: 1089: 1084: 1079: 1074: 1068: 1066: 1060: 1059: 1051: 1049: 1048: 1041: 1034: 1026: 1017: 1016: 1013: 1012: 1011: 1010: 1007: 996: 990: 984: 983: 980: 979: 976: 975: 973: 972: 967: 961: 959: 953: 952: 950: 949: 944: 939: 933: 931: 924: 920: 919: 916: 915: 913: 912: 907: 901: 896: 891: 880: 874: 872: 868: 867: 865: 864: 859: 853: 851: 845: 844: 842: 841: 835: 833: 827: 826: 824: 823: 813: 811: 804: 800: 799: 789: 787: 786: 779: 772: 764: 758: 757: 746: 743: 740: 739: 697: 696: 694: 691: 666: 663: 657: 654: 639:glucocorticoid 630: 627: 609:) is a hydroxy 586: 585: 574: 573: 571: 570: 567: 565: 562: 554: 553: 552: 549: 548: 546: 545: 542: 534: 533: 532: 529: 528: 525: 519: 518: 516: 515: 507: 505: 497: 496: 490: 484: 483: 480: 474: 468: 463: 457: 456: 452: 451: 441: 433: 432: 430: 429: 416: 414: 401: 400: 398: 397: 389: 387: 381: 380: 378: 377: 369: 367: 361: 360: 358: 357: 349: 347: 341: 340: 338: 337: 329: 327: 321: 320: 318: 317: 309: 307: 301: 300: 298: 297: 289: 287: 276: 275: 273: 272: 264: 262: 256: 255: 253: 252: 249: 241: 240: 239: 236: 235: 231: 230: 227: 221: 220: 217: 208: 207: 204: 198: 197: 194: 188: 187: 184: 178: 177: 170: 169: 167: 166: 152: 150: 144: 143: 139: 138: 136: 135: 122: 120: 114: 113: 110: 108:administration 102: 101: 99: 98: 96: 86: 84: 76: 75: 68: 58: 57: 53: 52: 44: 43: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 1243: 1232: 1229: 1227: 1224: 1222: 1219: 1217: 1214: 1212: 1209: 1207: 1204: 1203: 1201: 1186: 1183: 1182: 1180: 1178: 1174: 1168: 1165: 1163: 1160: 1158: 1155: 1153: 1150: 1148: 1145: 1143: 1140: 1138: 1135: 1133: 1130: 1128: 1125: 1123: 1120: 1118: 1115: 1113: 1110: 1108: 1105: 1103: 1100: 1098: 1095: 1093: 1090: 1088: 1085: 1083: 1080: 1078: 1075: 1073: 1070: 1069: 1067: 1065: 1061: 1057: 1054: 1047: 1042: 1040: 1035: 1033: 1028: 1027: 1024: 1008: 1006: 1003: 1002: 1000: 997: 994: 991: 989: 986: 985: 981: 971: 968: 966: 963: 962: 960: 958: 954: 948: 945: 943: 940: 938: 935: 934: 932: 928: 925: 921: 911: 908: 905: 902: 900: 897: 895: 892: 890: 886: 885: 881: 879: 876: 875: 873: 869: 863: 860: 858: 855: 854: 852: 850: 846: 840: 837: 836: 834: 832: 828: 822: 818: 815: 814: 812: 808: 805: 801: 796: 792: 785: 780: 778: 773: 771: 766: 765: 762: 755: 752: 749: 748: 744: 735: 731: 726: 721: 717: 713: 709: 702: 699: 692: 690: 686: 682: 680: 676: 675:free radicals 672: 664: 662: 655: 653: 651: 647: 643: 640: 636: 628: 626: 624: 620: 616: 612: 608: 604: 600: 596: 592: 582: 575: 566: 561: 557: 550: 541: 537: 530: 526: 524: 523:Melting point 520: 513: 509: 508: 506: 503: 498: 491: 489: 485: 464: 462: 458: 453: 449: 445: 442: 440: 438:ECHA InfoCard 434: 426: 422: 421:DTXSID7024538 418: 417: 415: 406: 402: 395: 391: 390: 388: 386: 382: 375: 371: 370: 368: 366: 362: 355: 351: 350: 348: 346: 342: 335: 331: 330: 328: 326: 322: 315: 311: 310: 308: 306: 302: 295: 291: 290: 288: 281: 277: 270: 266: 265: 263: 261: 257: 248: 244: 237: 232: 228: 226: 222: 218: 216: 209: 205: 203: 199: 195: 193: 189: 185: 183: 179: 175: 171: 164: 154: 153: 151: 149: 145: 140: 132: 127: 124: 123: 121: 119: 115: 111: 109: 103: 97: 88: 87: 85: 83: 77: 73: 69: 67: 63: 59: 56:Clinical data 54: 50: 45: 41: 36: 19: 1231:TSPO ligands 1096: 889:Calcipotriol 882: 878:Fumaric acid 838: 753: 718:(1): S42-4. 715: 711: 701: 687: 683: 671:mitochondria 668: 665:Pharmacology 659: 656:Side effects 632: 629:Medical uses 598: 590: 589: 578:   212:Elimination 148:Legal status 142:Legal status 1216:Anthracenes 1177:Antagonists 1157:SSR-180,575 995:from market 942:Methoxsalen 937:Trioxysalen 862:Methoxsalen 857:Trioxysalen 619:medications 605:and former 495: g·mol 444:100.013.216 394:ChEMBL46469 374:CHEBI:37510 234:Identifiers 1200:Categories 1056:modulators 965:Etretinate 910:Tazarotene 904:Tacalcitol 899:Calcitriol 756:March 2003 693:References 615:anthracene 500:3D model ( 488:Molar mass 334:U8CJK0JH5M 305:ChemSpider 260:CAS Number 243:IUPAC name 202:Metabolism 1147:Olesoxime 1137:FGIN-1-43 1132:FGIN-1-27 1127:Etifoxine 1005:Phase III 993:Withdrawn 970:Acitretin 957:Retinoids 947:Bergapten 930:Psoralens 884:vitamin D 849:Psoralens 839:Dithranol 831:Antracens 646:anthralin 635:psoriasis 623:psoriasis 599:anthralin 591:Dithranol 269:1143-38-0 225:Excretion 214:half-life 161: P ( 106:Routes of 80:Pregnancy 66:Drugs.com 32:Dithranol 18:Anthralin 1185:PK-11195 1167:YL-IPA08 1152:Ro5-4864 1122:Emapunil 1102:Diazepam 1082:DAA-1106 1077:DAA-1097 1064:Agonists 923:Systemic 821:Coal tar 734:24326551 642:steroids 611:anthrone 581:(verify) 118:ATC code 95: B2 82:category 1211:Phenols 1117:DPA-714 1112:DPA-713 1072:Alpidem 803:Topical 493:226.231 461:Formula 280:PubChem 134:) 128: ( 126:D05AC01 112:topical 988:WHO-EM 732:  536:SMILES 385:ChEMBL 354:D00233 1142:GML-1 871:Other 597:) or 556:InChI 502:JSmol 365:ChEBI 1162:W-18 810:Tars 730:PMID 679:cGMP 603:USAN 345:KEGG 325:UNII 314:2117 294:2202 176:data 62:AHFS 817:Tar 795:D05 720:doi 607:BAN 595:INN 410:EPA 284:CID 229:n/a 219:n/a 131:WHO 1202:: 1001:: 819:/ 754:45 728:. 716:16 714:. 710:. 652:. 613:, 475:10 469:14 196:0% 157:UK 91:AU 1045:e 1038:t 1031:v 906:) 887:( 797:) 793:( 783:e 776:t 769:v 736:. 722:: 601:( 593:( 504:) 481:3 478:O 472:H 466:C 412:) 408:( 165:) 159:: 93:: 64:/ 20:)

Index

Anthralin


AHFS
Drugs.com
Micromedex Detailed Consumer Information
Pregnancy
category

Routes of
administration

ATC code
D05AC01
WHO
Legal status
Pharmacy medicines
Pharmacokinetic
Bioavailability
Protein binding
Metabolism
Elimination half-life
Excretion
IUPAC name
CAS Number
1143-38-0
PubChem
2202
ChemSpider
2117
UNII
U8CJK0JH5M
KEGG
D00233

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.